香港中文大学（深圳）于2018年11月14日宣布正式成立生命与健康科学学院(School of Life and Health Sciences)，是港中大（深圳）继经管学院、理工学院、人文社科学院后的第四所具有从本科及研究生培养体系的学院。
生命与健康科学学院将专注于生命与健康科学的教学、科研与创新，致力于成为国际知名的生命与健康科学学院，为学生提供高瞻远瞩的教育机会，开展具有全球影响力的跨学科研究，为生命和健康科学的专业发展、社群发展提供卓越服务。学院课程设置将整合生命科学、健康科学、科研与生物工程设计等，旨在以严谨多元的教育模式，培养出一批该领域的领导者和创新者。
The Chinese University of Hong Kong, Shenzhen officially announced the establishment of the School of Life and Health Sciences on November 14th, 2018, which is the fourth school of CUHK-Shenzhen proceded by the School of Management and Economics (SME), the School of Sciences and Engineering (SSE), and the School of Humanities and Social Sciences (HSS), offering educational programs from baccalaureate to graduate degrees.
The School of Life and Health Sciences (LHS) at CUHK-Shenzhen is to pursue excellence in teaching, research and innovation in life and health sciences for the benefit of human health and well-being. LHS strives to be an internationally recognized life and health science school that offers inspiring educational opportunities for students, conducts interdisciplinary research projects with global impact, and serves the life and health science profession and the community with distinction. The curriculum of LHS will integrate life sciences, health sciences, scientific research and bioengineering design, aiming to cultivate a group of leaders and innovators in this field through a rigorous and diversified mode of education.
生命与健康科学学院创院院长叶德全教授
校长讲席教授
Professor Richard Ye，Founding Dean of LHS
Presidential Chair Professor
2019年2月1日，生命与健康科学学院创院院长叶德全教授正式履任。叶德全教授1982年本科毕业于上海第二医学院（现上海交通大学医学院），并于1988年获美国圣路易斯华盛顿大学博士学位。自1989年起先后在Scripps研究所及伊利诺伊大学医学院担任助理教授、副教授、教授，其科研项目获美国国立健康研究院资助达25年。
他的主要研究方向包括G蛋白偶联受体的信号转导及其在固有免疫细胞中的作用，炎症机制和病理模型及相关药物靶标的发现。叶教授先后与强生、诺华、GSK等公司开展研发合作，作为第一发明人获批美国专利2项、中国专利1项、共同发明人专利2项。他发表SCI学术论文198篇，被引1万多次。
叶教授于2010年回国担任上海交通大学讲席教授、药学院院长；2015年1月至2019年1月任澳门大学讲座教授。其学术兼职包括THE FASEB Journal副主编、Pharmacological Reviews副主编、Physiological Reviews副主编、Molecular Pharmacology及British Journal of Pharmacology 编委。
On February 1st 2019, Professor Ye is officially appointed as the Founding Dean of LHS. Professor Ye graduated from Shanghai Second Medical College (Now Shanghai Jiao Tong University School of Medicine) in 1982 and received his Ph.D. from Washington University in St. Louis, USA in 1988. Since 1989, he has served as an Assistant Professor, Associate Professor, and Professor at Scripps Research Institute and the University of Illinois College of Medicine. His research projects have been continuously funded by the National Institutes of Health for 25 years.
His main research interests include signal transduction of G protein-coupled receptors and their roles in innate immune cells, inflammatory mechanisms and pathological models, and the discovery of related drug targets. He has collaborated with Johnson & Johnson, Novartis, GSK and other companies on new drug discovery. He was granted 2 US patents, 1 Chinese patent as the first inventor, and 2 joint inventor patents. He has published 198 research papers on SCI journals, having been cited for more than 10,000 times.
In 2010, Professor Ye returned to China as Chair Professor at Shanghai Jiao Tong University and Dean of the School of Pharmacy. From January 2015 to January 2019, he served as Chair Professor at the University of Macau. Other Academic engagement including serving as an Associate Editor of THE FASEB Journal, Associate Editor of Pharmacological Reviews, Associate Editor of Physiology Reviews, and member of the editorial boards of the British Journal of Pharmacology and Molecular Pharmacology.
生命与健康科学学院秉承香港中文大学的优良学术传统和严谨治学精神，立足三个“诺奖研究院”的科研基础，瞄准学科前沿和长远目标，开设本科、硕士和博士学位课程。
港中大教务会负责审批和监督学位课程，指导及管理授课和教学有关事宜，监管港中大（深圳）学位资格认证的水准。香港中文大学（深圳）毕业生获颁香港中文大学学位证书。生命与健康科学学院于2019年度开始招收生物信息学本科生入学，并将在2020年起先后开设药学科学及生物医学科学方向本科专业。
Inheriting the excellent academic traditions and rigorous academic spirit of the Chinese University of Hong Kong, established upon the research foundations of the three Nobel Prize Research Institutes, aiming at the frontiers and long-term goals of the disciplines, the School of Life and Health Sciences shall offer undergraduate, master's and doctoral degrees.
The Academic Board of the Chinese University of Hong Kong take charge of the approval and supervision of degree programs, guiding and managing teaching and teaching-related matters, and supervising the level of CUHK-Shenzhen degree qualification. CUHK-Shenzhen graduates are awarded degree certificates by the Chinese University of Hong Kong. The School of Life and Health Sciences will be open for undergraduate admission in Bioinformatics major in 2019 and Pharmaceutical Sciences and Biomedical Sciences in 2020.
